CD8 + T cells can inhibit tumor growth by inducing pyroptosis of tumor cells, whereas the inflammatory molecules derived from cell lysis can also affect the tumor immune microenvironment as well as the efficacy of tumor immunotherapy [17, 39]. The gene discussed is CD8A; the disease is neoplasm.